Novanta Inc (NOVT)

Currency in USD
159.70
+4.82(+3.11%)
Closed·
159.700.00(0.00%)
·
NOVT is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
154.20160.09
52 wk Range
98.27165.56
Key Statistics
Prev. Close
154.88
Open
155.36
Day's Range
154.2-160.09
52 wk Range
98.27-165.56
Volume
277.38K
Average Volume (3m)
430.69K
1-Year Change
31.009%
Book Value / Share
36.74
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
NOVT Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
171.50
Upside
+7.39%
Members' Sentiments
Bearish
Bullish
ProTips
2 analysts have revised their earnings downwards for the upcoming period

Novanta Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Analyst Ratings

3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 171.50
(+7.39% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Baird
Buy173.00+8.33%144.00Maintain13/05/2026
Baird
Buy144.00-9.83%150.00Upgrade30/03/2026
Baird
Hold150.00-6.07%138.00Maintain25/02/2026
Baird
Hold138.00-13.59%133.00Maintain05/11/2025
Baird
Hold133.00-16.72%139.00Maintain11/08/2025

Novanta Inc Earnings Call Summary for Q1/2026

  • Q1 2026 revenue rose 10% YoY to $257.7M, beating estimates by 1.65%; EPS of $0.81 missed forecast by 2.41% but grew 9% YoY
  • Bookings surged 37% YoY while operating cash flow jumped 63%, signaling strong demand; adjusted EBITDA increased 14% to $57M
  • Stock climbed 7.16% in pre-market to $150, later reaching $156.79; shares trade at high P/E of 94x near 52-week high
  • Management maintains optimistic outlook driven by high-growth markets in advanced surgery and robotics despite margin pressure from tariffs
  • Analysts rate stock Outperform with price targets $144-$170; company focuses on innovation and regional manufacturing consolidation
Last Updated: 12/05/2026, 15:14
Read Full Transcript

Earnings

Latest Release
11/05/2026
EPS / Forecast
0.81 / 0.83
Revenue / Forecast
257.7M / 253.51M
EPS Revisions
Last 90 days

Compare NOVT to Peers and Sector

Metrics to compare
NOVT
Peers
Sector
Relationship
P/E Ratio
105.7x85.5x12.7x
PEG Ratio
−3.70−0.220.01
Price/Book
4.3x4.1x2.4x
Price / LTM Sales
5.7x7.5x2.4x
Upside (Analyst Target)
11.7%30.0%22.5%
Fair Value Upside
Unlock−5.4%2.8%Unlock

Novanta Inc., together with its subsidiaries, provides precision medicine, precision manufacturing, medical solutions, robotics and automation solutions, and advanced surgery solutions in the United States and internationally. The company operates Automation Enabling Technologies and Medical Solutions segments. The Precision Medicine and Manufacturing segment designs, manufactures, and markets laser beam steering and scanning solutions, laser sources, robotic and precision motion, robotic end-of-arm tooling, and bearing spindles. This segment serves advanced industrial processes, advanced industrial and medical robotics, other medical and life science automation applications, and medical laser procedures, such as ophthalmology applications. The Medical Solutions segment provides a range of medical grade technologies, including medical insufflators, pumps, and related disposables; imaging, identification and RFID solutions; advanced motion control solutions; and light engines, and integrated operating room technologies. The company was formerly known as GSI Group, Inc. and changed its name to Novanta Inc. in May 2016. Novanta Inc. was incorporated in 1968 and is based in Bedford, Massachusetts.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
23.68M66.50%3.67B
Other Institutional Investors
17.48M33.50%2.71B
Public Companies & Retail Investors
0.000.00%0.00
Total
41.17M100.00%6.38B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
BlackRock, Inc.12.86%4,580,729709,463
The Vanguard Group, Inc.12.19%4,340,698672,287

People Also Watch

11.23
MEI
+4.13%
29.51
BLKB
-0.37%
119.76
TKR
+0.70%
35.83
APOG
+1.50%
222.59
OSIS
+7.08%

FAQ

What Is the Novanta (NASDAQ: NOVT) Share Price Today?

The Novanta stock price today is 159.70 USD.

What Stock Exchange Does Novanta (NOVT) Trade On?

Novanta is listed and trades on the Nasdaq Stock Exchange.

What Is the Ticker (Stock Symbol) for Novanta?

The stock symbol (also called a 'ticker') for Novanta is "NOVT."

What Is the Current Novanta Market Capitalisation?

As of today, Novanta (NASDAQ: NOVT) market cap is 5.67B USD.

What Is Novanta's (NOVT) Earnings Per Share (TTM)?

The Novanta EPS is currently 1.41 (Trailing Twelve Months).

When Is the Next Novanta Earnings Date?

Novanta's next earnings report will be released on 11/08/2026.

Is NOVT a Buy or Sell From a Technical Analyst Perspective?

Based on today's Novanta moving averages and other technical indicators, the daily buy/sell signal for NOVT stock is Strong Buy.

How Many Times Has Novanta Stock Split?

Novanta has split 1 times. (See the NOVT stock split history page for full effective split date and price information.)

How Many Employees Does Novanta Have?

Novanta has 3000 employees, based on their latest Companies House report.

What is the current trading status of Novanta (NASDAQ: NOVT)?

As of 22/05/2026, Novanta (NOVT) is trading at a share price of 159.70 USD, with a previous close of 154.88 USD. The stock has fluctuated within a day range of 154.20 USD to 160.09 USD, while its 52-week range spans from 98.27 USD to 165.56 USD.

What Is Novanta (NOVT) Price Target According to Analysts?

The average 12-month price target for Novanta is 171.50 USD, with a high estimate of 173 USD and a low estimate of 170 USD. 3 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +7.39% Upside potential.

What Is the NOVT Premarket Price?

NOVT's last pre-market stock price is 155.35 USD. The pre-market share volume is 371.00, and the stock has decreased by 0.47, or 0.30%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.